-+ 0.00%
-+ 0.00%
-+ 0.00%

On August 13, local time, according to reports, people familiar with the matter revealed that an affiliate of private equity investment company KKR is selling shares of biotechnology company BridgeBio Pharma at a price of 78 to 80 US dollars per share.

Zhitongcaijing·08/14/2026 00:41:19
Listen to the news
On August 13, local time, according to reports, people familiar with the matter revealed that an affiliate of private equity investment company KKR is selling shares of biotechnology company BridgeBio Pharma at a price of 78 to 80 US dollars per share.